Institute of Biomaterials and Biomedical Engineering, University of Toronto, 164 College Street, Toronto, Ontario, Canada.
J Biomed Mater Res A. 2010 Aug;94(2):660-6. doi: 10.1002/jbm.a.32666.
We have recently shown that a new implant surface design, achieved by the deposition of discrete nanocrystals of calcium phosphate on microtopographically complex titanium-based substrates, accelerates osteoconduction and also renders the implant surface bone bonding. Thus, we wished to examine the elution behavior of these calcium phosphate nanocrystals and their modulation in vivo. We first compared the total amount of calcium phosphate on these implants with that of plasma-sprayed implants, by measuring the eluted calcium using atomic absorption spectrophotometry. We then plotted their dissolution behavior in vitro as a function of pH relevant to physiological conditions. To assess their structural stability in vivo for periods of up to 1 month, we placed samples in diffusion chambers, implanted them in the abdominal cavity of rats, and examined their surfaces by scanning electron microscopy following retrieval. Our results show that these nanocrystals are stable at normal pH but, as expected, dissolve at acidic pH, and that they remain unchanged when exposed to body fluid in vivo for up to 1 month.
我们最近发现,通过在微形貌复杂的钛基基底上沉积离散的磷酸钙纳米晶体,可以实现一种新的植入物表面设计,这种设计可以加速骨传导,并使植入物表面与骨骼结合。因此,我们希望研究这些磷酸钙纳米晶体的洗脱行为及其在体内的调节。我们首先通过原子吸收分光光度法测量洗脱的钙,比较了这些植入物上的磷酸钙总量与等离子喷涂植入物上的磷酸钙总量。然后,我们将它们的体外溶解行为绘制为与生理条件相关的 pH 值的函数。为了评估它们在长达 1 个月的时间内在体内的结构稳定性,我们将样品放置在扩散室内,将其植入大鼠的腹腔中,并在取回后通过扫描电子显微镜检查其表面。我们的结果表明,这些纳米晶体在正常 pH 值下稳定,但如预期的那样,在酸性 pH 值下溶解,并且在体内暴露于体液中长达 1 个月时保持不变。